The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Chromatin & Transcription | Proteins
The EMBO Journal (2002) 21, 2682–2691, doi: 10.1093/emboj/21.11.2682
The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase
Olivier Kirsh1, 7, Jacob-S. Seeler1, 7, Andrea Pichler2, Andreas Gast2, Stefan Müller1, 3, Eric Miska4, 5, Marion Mathieu6, Annick Harel-Bellan6, Tony Kouzarides4, Frauke Melchior2 and Anne Dejean1
1 Unité de Recombinaison et Expression Génétique, INSERM U 163, Institut Pasteur, 28 rue du Dr Roux, F-75724 Paris Cedex 15, France
2 Max Planck Institute for Biochemistry, Am Klopferspitz 18a, D-82152 Martinsried, Germany
3 Present address: Max Planck Institute of Biochemistry, Department of Molecular Cell Biology, Am Klopferspitz 18a, D-82152 Martinsried, Germany
4 Wellcome/CRC Institute, Department of Pathology, Cambridge University, Tennis Court Road, Cambridge CB2 1QR, UK
5 Present address: Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA
6 Laboratoire Oncogénèse, Différenciation et Transduction du Signal, CNRS UPR 9079, IFC-O1, F-94801 Villejuif, France
7 O.Kirsh and J.-S.Seeler contributed equally to this work

To whom correspondence should be addressed
Anne Dejean, adejean@pasteur.fr

Received 4 January 2002; Revised 9 April 2002; Accepted 11 April 2002.
Abstract
Transcriptional repression mediated through histone deacetylation is a critical component of eukaryotic gene regulation. Here we demonstrate that the class II histone deacetylase HDAC4 is covalently modified by the ubiquitin-related SUMO-1 modifier. A sumoylation-deficient point mutant (HDAC4-K559R) shows a slightly impaired ability to repress transcription as well as reduced histone deacetylase activity. The ability of HDAC4 to self-aggregate is a prerequisite for proper sumoylation in vivo. Calcium/calmodulin-dependent protein kinase (CaMK) signalling, which induces nuclear export, abrogates SUMO-1 modification of HDAC4. Moreover, the modification depends on the presence of an intact nuclear localization signal and is catalysed by the nuclear pore complex (NPC) RanBP2 protein, a factor newly identified as a SUMO E3 ligase. These findings suggest that sumoylation of HDAC4 takes place at the NPC and is coupled to its nuclear import. Finally, modification experiments indicate that the MEF2-interacting transcription repressor (MITR) as well as HDAC1 and -6 are similarly SUMO modified, indicating that sumoylation may be an important regulatory mechanism for the control of transcriptional repression mediated by both class I and II HDACs.
Keywords: E3 ligase, HDACs, nuclear pore complex, SUMO, ubiquitin-like modification
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2002 by the European Molecular Biology Organization